Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Todd Lee and Matthew Cheng.
Todd Lee
Connection Strength
4.162
Matthew Cheng
  1. Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis. Open Forum Infect Dis. 2019 Jul 01; 6(7).
    View in: PubMed
    Score: 0.830
  2. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial. Trials. 2018 May 29; 19(1):297.
    View in: PubMed
    Score: 0.770
  3. The Reply. Am J Med. 2018 04; 131(4):e157.
    View in: PubMed
    Score: 0.761
  4. Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis. Crit Care Med. 2021 09 01; 49(9):1558-1566.
    View in: PubMed
    Score: 0.241
  5. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis. Int J Infect Dis. 2021 Mar; 104:671-676.
    View in: PubMed
    Score: 0.232
  6. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic. CMAJ. 2020 Apr 14; 192(15):E405-E407.
    View in: PubMed
    Score: 0.218
  7. MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis. J Infect. 2018 12; 77(6):489-495.
    View in: PubMed
    Score: 0.195
  8. Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus. Antimicrob Agents Chemother. 2018 07; 62(7).
    View in: PubMed
    Score: 0.193
  9. Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia. BMC Infect Dis. 2018 06 11; 18(1):270.
    View in: PubMed
    Score: 0.193
  10. Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae. Clin Infect Dis. 2018 04 03; 66(8):1282-1285.
    View in: PubMed
    Score: 0.190
  11. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study. CMAJ Open. 2021 Jan-Mar; 9(1):E181-E188.
    View in: PubMed
    Score: 0.058
  12. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
    View in: PubMed
    Score: 0.057
  13. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
    View in: PubMed
    Score: 0.056
  14. Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial. Trials. 2020 Jul 03; 21(1):610.
    View in: PubMed
    Score: 0.056
  15. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
    View in: PubMed
    Score: 0.055
  16. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.